PMID- 29405769 OWN - NLM STAT- MEDLINE DCOM- 20190107 LR - 20190107 IS - 1477-0903 (Electronic) IS - 0960-3271 (Linking) VI - 37 IP - 10 DP - 2018 Oct TI - Thymoquinone alleviates the experimentally induced Alzheimer's disease inflammation by modulation of TLRs signaling. PG - 1092-1104 LID - 10.1177/0960327118755256 [doi] AB - Alzheimer's disease (AD) is characterized by a robust inflammatory response elicited by the accumulation and deposition of amyloid-beta (Abeta) within the brain. Abeta induces detrimental inflammatory responses through toll-like receptors (TLRs) signaling pathway. Thymoquinone (TQ), the main active constituent of Nigella sativa oil, has been reported by several previous studies for its potent anti-inflammatory effect. The aim of this study is to elucidate the effect of TQ in improving learning and memory, using a rat model of AD induced by a combination of aluminum chloride (AlCl(3)) and d-galactose (d-Gal). TQ was administered orally at doses of 10, 20, and 40 mg/kg/day for 14 days after AD induction. Memory functions were assessed using the step through passive avoidance test. Amyloid plaques were shown to be present using hematoxylin and eosin staining. Tumor necrosis factor-alpha (TNF-alpha) and Interleukin-1beta (IL-1beta) levels in brain were assessed via ELISA and profiling TLR-2, TLR-4, myeloid differential factor 88, toll-interleukin-1 receptor domain-containing adapter-inducing interferon-beta, interferon regulatory factor 3 (IRF-3), and nuclear factor-kappaB (NF-kappaB) expressions via real-time polymerase chain reaction. TQ improved AD rat cognitive decline, decreased Abeta formation and accumulation, significantly decreased TNF-alpha and IL-1beta at all levels of doses and significantly downregulated the expression of TLRs pathway components as well as their downstream effectors NF-kappaB and IRF-3 mRNAs at all levels of doses ( p < 0.05). We concluded that TQ reduced the inflammation induced by d-Gal/AlCl(3) combination. It is therefore reasonable to assign the anti-inflammatory responses to the modulation of TLRs pathway. FAU - Abulfadl, Y S AU - Abulfadl YS AD - 1 Department of Pharmacology, Toxicology, and Biochemistry, Faculty of Pharmaceutical Sciences and Pharmaceutical Industries, Future University, Cairo, Egypt. FAU - El-Maraghy, N N AU - El-Maraghy NN AD - 1 Department of Pharmacology, Toxicology, and Biochemistry, Faculty of Pharmaceutical Sciences and Pharmaceutical Industries, Future University, Cairo, Egypt. FAU - Ahmed, Aa Eissa AU - Ahmed AE AD - 2 Department of Pharmacology and Toxicology, Faculty of Pharmacy, Helwan University, Helwan, Egypt. FAU - Nofal, S AU - Nofal S AD - 2 Department of Pharmacology and Toxicology, Faculty of Pharmacy, Helwan University, Helwan, Egypt. FAU - Abdel-Mottaleb, Y AU - Abdel-Mottaleb Y AD - 1 Department of Pharmacology, Toxicology, and Biochemistry, Faculty of Pharmaceutical Sciences and Pharmaceutical Industries, Future University, Cairo, Egypt. FAU - Badary, O A AU - Badary OA AD - 3 Department of Clinical Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt. LA - eng PT - Journal Article DEP - 20180206 PL - England TA - Hum Exp Toxicol JT - Human & experimental toxicology JID - 9004560 RN - 0 (Benzoquinones) RN - 0 (Interleukin-1beta) RN - 0 (Tlr2 protein, rat) RN - 0 (Tlr4 protein, rat) RN - 0 (Toll-Like Receptor 2) RN - 0 (Toll-Like Receptor 4) RN - 0 (Tumor Necrosis Factor-alpha) RN - 3CYT62D3GA (Aluminum Chloride) RN - O60IE26NUF (thymoquinone) RN - X2RN3Q8DNE (Galactose) SB - IM MH - Aluminum Chloride/toxicity MH - Alzheimer Disease/metabolism/pathology/*prevention & control MH - Animals MH - Benzoquinones/*pharmacology MH - Disease Models, Animal MH - Dose-Response Relationship, Drug MH - Galactose/toxicity MH - Gene Expression Profiling MH - Inflammation/chemically induced/metabolism/*prevention & control MH - Interleukin-1beta/metabolism MH - Learning MH - Male MH - Memory MH - Rats MH - Rats, Sprague-Dawley MH - Real-Time Polymerase Chain Reaction MH - Signal Transduction/*drug effects MH - Toll-Like Receptor 2/genetics/*metabolism MH - Toll-Like Receptor 4/genetics/*metabolism MH - Tumor Necrosis Factor-alpha/metabolism OTO - NOTNLM OT - Alzheimer's disease OT - IL-1beta OT - TLR-2 OT - TLR-4 OT - TNF-alpha OT - thymoquinone EDAT- 2018/02/07 06:00 MHDA- 2019/01/08 06:00 CRDT- 2018/02/07 06:00 PHST- 2018/02/07 06:00 [pubmed] PHST- 2019/01/08 06:00 [medline] PHST- 2018/02/07 06:00 [entrez] AID - 10.1177/0960327118755256 [doi] PST - ppublish SO - Hum Exp Toxicol. 2018 Oct;37(10):1092-1104. doi: 10.1177/0960327118755256. Epub 2018 Feb 6.